Trials / Unknown
UnknownNCT04393376
PSA Glycomics Assay for Early Detection of Prostate Cancer
Evaluation of Prostate-Specific Antigen Glycomics Assay for the Early Detection of Prostate Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Prof.dr. H.P. Beerlage · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The principal aim of this pilot study is to test whether the PSA Glycomics Assay on urine and serum samples can provide insights regarding the disease state of patients with elevated PSA concentrations, as well as to accurately identify if the patient has prostate cancer and, in the case of prostate cancer, to determine its level of aggressiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PSA Glycomics Assay | PSA Glycomics Assay will be performed on urine and blood samples |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2024-01-01
- Completion
- 2025-08-01
- First posted
- 2020-05-19
- Last updated
- 2023-09-26
Locations
3 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04393376. Inclusion in this directory is not an endorsement.